These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8886916)

  • 1. Comparison of the Equil2 program and other methods for estimating the ion-activity product of urinary calcium oxalate: a new simplified method is proposed.
    Ogawa Y; Hatano T
    Int J Urol; 1996 Sep; 3(5):383-5. PubMed ID: 8886916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approximate estimate of the ion-activity product of calcium oxalate in rat urine.
    Tiselius HG; Ferraz RR; Heilberg IP
    Urol Res; 2003 Dec; 31(6):410-3. PubMed ID: 14579106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine.
    Tiselius HG; Ferraz RR; Heilberg IP
    Urol Res; 2012 Aug; 40(4):285-91. PubMed ID: 22200737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: an application of the EQUIL2 program.
    Robert M; Boularan AM; Colette C; Averous M; Monnier L
    Br J Urol; 1994 Apr; 73(4):358-61. PubMed ID: 8199821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of estimation of the urinary ion-activity products of calcium oxalate and calcium phosphate.
    Ogawa Y
    Hinyokika Kiyo; 1993 May; 39(5):407-11. PubMed ID: 8322621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation.
    Ogawa Y; Hatano T
    Int J Urol; 1996 Sep; 3(5):356-60. PubMed ID: 8886911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
    Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
    Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
    Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
    Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
    Tiselius HG; Sandvall K
    Eur Urol; 1990; 17(3):206-12. PubMed ID: 2351189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects.
    Siener R; Hesse A
    Eur Urol; 2002 Sep; 42(3):289-96. PubMed ID: 12234515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate.
    Pak CY; Maalouf NM; Rodgers K; Poindexter JR
    J Urol; 2009 Dec; 182(6):2951-6. PubMed ID: 19846163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposed method for approximate estimates of the ion-activity products of calcium oxalate and calcium phosphate in spot-urine samples or in urine samples collected during less well defined periods of time.
    Tiselius HG
    Urolithiasis; 2013 Apr; 41(2):105-9. PubMed ID: 23503871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
    Tiselius HG
    Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized estimate of the ion activity product of calcium oxalate in urine from renal stone formers.
    Tiselius HG
    Eur Urol; 1989; 16(1):48-50. PubMed ID: 2714318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a simple test to estimate urine saturation with calcium oxalate in stone-forming patients.
    Sánchez A; González A; Sarano HD; Reinaldi S
    Int J Urol; 1994 Dec; 1(4):316-8. PubMed ID: 7614393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of at-home prediction of the formation of urolithiasis by simple multi-frequency electrical conductivity of the urine and the comparison of its performance with urine ion-related indices, color and specific gravity.
    Silverio AA; Chung WY; Cheng C; Wang HL; Kung CM; Chen J; Tsai VF
    Urolithiasis; 2016 Apr; 44(2):127-34. PubMed ID: 26271351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sodium-potassium citrate on the diurnal variations in urinary calcium oxalate and calcium phosphate saturation levels in normal individuals.
    Ogawa Y
    Br J Urol; 1994 Feb; 73(2):136-41. PubMed ID: 8131014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.